Fidaxomicin versus Vancomycin for Clostridium difficile Infection

Thomas J. Louie; Mark A. Miller; Kathleen M. Mullane; Karl Weiss; Arnold Lentnek; Yoav Golan; Sherwood Gorbach; Pamela Sears; Youe-Kong Shue

doi:10.1056/nejmoa0910812

Fidaxomicin versus Vancomycin for Clostridium difficile Infection

Identifier:nobleid.org/w1/20260526/3DF03F35

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3DF03F35.svg?ark=w1%2F20260526%2F3DF03F35)](https://nobleid.org/work/w1/20260526/3DF03F35)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Fidaxomicin versus Vancomycin for Clostridium difficile Infection

Identifier:nobleid.org/w1/20260526/3DF03F35

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3DF03F35.svg?ark=w1%2F20260526%2F3DF03F35)](https://nobleid.org/work/w1/20260526/3DF03F35)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work